{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:35:20Z","timestamp":1793932520939,"version":"4.8.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271747"],"award-info":[{"award-number":["82271747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.gendis.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T06:54:28Z","timestamp":1681368868000},"page":"675-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["CRISPR\/Cas9 system and its applications in nervous system diseases"],"prefix":"10.1016","volume":"11","author":[{"given":"Haibin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zidi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mopu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-0944","authenticated-orcid":false,"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ymthe.2019.01.014","article-title":"Genome editing with mRNA encoding ZFN, TALEN, and Cas9","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol Ther"},{"issue":"Pt 3","key":"10.1016\/j.gendis.2023.03.017_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1099\/mic.0.023960-0","article-title":"Short motif sequences determine the targets of the prokaryotic CRISPR defence system","volume":"155","author":"Mojica","year":"2009","journal-title":"Microbiology (Read)"},{"issue":"12","key":"10.1016\/j.gendis.2023.03.017_bib3","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nbt.3715","article-title":"Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library","volume":"34","author":"Zhu","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.gendis.2023.03.017_bib4","doi-asserted-by":"crossref","first-page":"16139","DOI":"10.1038\/nplants.2016.139","article-title":"Gene replacements and insertions in rice by intron targeting using CRISPR-Cas9","volume":"2","author":"Li","year":"2016","journal-title":"Native Plants"},{"issue":"29","key":"10.1016\/j.gendis.2023.03.017_bib5","doi-asserted-by":"crossref","first-page":"15226","DOI":"10.1074\/jbc.M116.724062","article-title":"Gene repression in haloarchaea using the CRISPR (clustered regularly interspaced short palindromic repeats)-Cas I-B system","volume":"291","author":"Stachler","year":"2016","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nprot.2017.016","article-title":"Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening","volume":"12","author":"Joung","year":"2017","journal-title":"Nat Protoc"},{"issue":"6096","key":"10.1016\/j.gendis.2023.03.017_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.gendis.2023.03.017_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.57.3.418","article-title":"The global burden of disease study: implications for neurology","volume":"57","author":"Menken","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gendis.2023.03.017_bib9","doi-asserted-by":"crossref","first-page":"803894","DOI":"10.3389\/fnins.2021.803894","article-title":"Application of CRISPR\/Cas9 in Alzheimer's disease","volume":"15","author":"Lu","year":"2021","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10571-019-00761-w","article-title":"CRISPR system: a high-throughput toolbox for research and treatment of Parkinson's disease","volume":"40","author":"Safari","year":"2020","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12264-022-00880-3","article-title":"CRISPR-based genome-editing tools for Huntington's disease research and therapy","volume":"38","author":"Qin","year":"2022","journal-title":"Neurosci Bull"},{"issue":"9","key":"10.1016\/j.gendis.2023.03.017_bib12","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3390\/cells10092342","article-title":"Applications of CRISPR-Cas9 technology to genome editing in glioblastoma multiforme","volume":"10","author":"Al-Sammarraie","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.gendis.2023.03.017_bib13","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s13311-021-01081-y","article-title":"Gene editing and modulation: the holy grail for the genetic epilepsies?","volume":"18","author":"Carpenter","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib14","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.3390\/ijms21113801","article-title":"CRISPR\/Cas9-mediated gene correction to understand ALS","volume":"21","author":"Yun","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gendis.2023.03.017_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrmicro1793","article-title":"CRISPR: a widespread system that provides acquired resistance against phages in bacteria and Archaea","volume":"6","author":"Sorek","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2958.2009.06641.x","article-title":"CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and dynamic properties","volume":"72","author":"Lillest\u00f8l","year":"2009","journal-title":"Mol Microbiol"},{"issue":"12","key":"10.1016\/j.gendis.2023.03.017_bib17","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1261\/rna.1246808","article-title":"Prokaryotic silencing (psi)RNAs in Pyrococcus furiosus","volume":"14","author":"Hale","year":"2008","journal-title":"RNA"},{"issue":"24","key":"10.1016\/j.gendis.2023.03.017_bib18","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1101\/gad.1742908","article-title":"Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes","volume":"22","author":"Carte","year":"2008","journal-title":"Genes Dev"},{"issue":"10","key":"10.1016\/j.gendis.2023.03.017_bib19","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1093\/nar\/gku241","article-title":"Classification and evolution of type II CRISPR-Cas systems","volume":"42","author":"Chylinski","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.gendis.2023.03.017_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrmicro2577","article-title":"Evolution and classification of the CRISPR-Cas systems","volume":"9","author":"Makarova","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"5819","key":"10.1016\/j.gendis.2023.03.017_bib21","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.gendis.2023.03.017_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.str.2009.03.019","article-title":"Structural basis for DNase activity of a conserved protein implicated in CRISPR-mediated genome defense","volume":"17","author":"Wiedenheft","year":"2009","journal-title":"Structure"},{"issue":"29","key":"10.1016\/j.gendis.2023.03.017_bib23","doi-asserted-by":"crossref","first-page":"20361","DOI":"10.1074\/jbc.M803225200","article-title":"A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats","volume":"283","author":"Beloglazova","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molcel.2013.09.013","article-title":"Structure and activity of the RNA-targeting type III-B CRISPR-Cas complex of Thermus thermophilus","volume":"52","author":"Staals","year":"2013","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrmicro3569","article-title":"An updated evolutionary classification of CRISPR\u2013Cas systems","volume":"13","author":"Makarova","year":"2015","journal-title":"Nat Rev Microbiol"},{"issue":"6176","key":"10.1016\/j.gendis.2023.03.017_bib26","doi-asserted-by":"crossref","first-page":"1247997","DOI":"10.1126\/science.1247997","article-title":"Structures of Cas9 endonucleases reveal RNA-mediated conformational activation","volume":"343","author":"Jinek","year":"2014","journal-title":"Science"},{"issue":"27","key":"10.1016\/j.gendis.2023.03.017_bib27","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1073\/pnas.1402597111","article-title":"Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes","volume":"111","author":"Szczelkun","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"39","key":"10.1016\/j.gendis.2023.03.017_bib28","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2023.03.017_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"Elife"},{"issue":"6121","key":"10.1016\/j.gendis.2023.03.017_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.gendis.2023.03.017_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrm2008","article-title":"Mechanism of homologous recombination: mediators and helicases take on regulatory functions","volume":"7","author":"Sung","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"10.1016\/j.gendis.2023.03.017_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"31","key":"10.1016\/j.gendis.2023.03.017_bib33","doi-asserted-by":"crossref","first-page":"21312","DOI":"10.1074\/jbc.M114.564625","article-title":"Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)\/Cas9 nuclease system in mammalian cells","volume":"289","author":"Canver","year":"2014","journal-title":"J Biol Chem"},{"issue":"6496","key":"10.1016\/j.gendis.2023.03.017_bib34","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.aay8204","article-title":"Very fast CRISPR on demand","volume":"368","author":"Liu","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.molcel.2020.06.014","article-title":"The histone chaperone FACT induces Cas9 multi-turnover behavior and modifies genome manipulation in human cells","volume":"79","author":"Wang","year":"2020","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.molcel.2018.06.005","article-title":"Enhanced bacterial immunity and mammalian genome editing via RNA-polymerase-mediated dislodging of Cas9 from double-strand DNA breaks","volume":"71","author":"Clarke","year":"2018","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair pathway choices and consequences at the double-strand break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41580-019-0152-0","article-title":"DNA double-strand break repair-pathway choice in somatic mammalian cells","volume":"20","author":"Scully","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.gendis.2023.03.017_bib39","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41556-019-0425-z","article-title":"Advances in genome editing through control of DNA repair pathways","volume":"21","author":"Yeh","year":"2019","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1083\/jcb.201103103","article-title":"Cdk1 uncouples CtIP-dependent resection and Rad51 filament formation during M-phase double-strand break repair","volume":"194","author":"Peterson","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1016\/j.gendis.2023.03.017_bib41","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1038\/ncomms10548","article-title":"RS-1 enhances CRISPR\/Cas9- and TALEN-mediated knock-in efficiency","volume":"7","author":"Song","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nbt.3190","article-title":"Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining","volume":"33","author":"Maruyama","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"24","key":"10.1016\/j.gendis.2023.03.017_bib43","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1038\/sj.emboj.7600469","article-title":"The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle","volume":"23","author":"Aylon","year":"2004","journal-title":"EMBO J"},{"issue":"7011","key":"10.1016\/j.gendis.2023.03.017_bib44","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nature02964","article-title":"DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1","volume":"431","author":"Ira","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2023.03.017_bib45","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/mt.2015.218","article-title":"Streptococcus thermophilus CRISPR-Cas9 systems enable specific editing of the human genome","volume":"24","author":"M\u00fcller","year":"2016","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib46","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nmeth.3312","article-title":"Highly efficient Cas9-mediated transcriptional programming","volume":"12","author":"Chavez","year":"2015","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib48","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.gendis.2023.03.017_bib49","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nmeth.2649","article-title":"Cas9 as a versatile tool for engineering biology","volume":"10","author":"Mali","year":"2013","journal-title":"Nat Methods"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib50","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41592-020-0966-x","article-title":"An efficient KRAB domain for CRISPRi applications in human cells","volume":"17","author":"Alerasool","year":"2020","journal-title":"Nat Methods"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib51","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.3390\/cells9112518","article-title":"CRISPR FokI dead Cas9 system: principles and applications in genome engineering","volume":"9","author":"Saifaldeen","year":"2020","journal-title":"Cells"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2023.03.017_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2016.10.044","article-title":"CRISPR-based technologies for the manipulation of eukaryotic genomes","volume":"168","author":"Komor","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2023.03.017_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.omtn.2017.02.006","article-title":"Optimizing the DNA donor template for homology-directed repair of double-strand breaks","volume":"7","author":"Song","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"issue":"13","key":"10.1016\/j.gendis.2023.03.017_bib54","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1093\/nar\/gky571","article-title":"How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editing","volume":"46","author":"Bollen","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"6305","key":"10.1016\/j.gendis.2023.03.017_bib55","doi-asserted-by":"crossref","first-page":"aaf8729","DOI":"10.1126\/science.aaf8729","article-title":"Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems","volume":"353","author":"Nishida","year":"2016","journal-title":"Science"},{"issue":"7603","key":"10.1016\/j.gendis.2023.03.017_bib56","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7681","key":"10.1016\/j.gendis.2023.03.017_bib57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2023.03.017_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13059-018-1443-z","article-title":"Expanded base editing in rice and wheat using a Cas9-adenosine deaminase fusion","volume":"19","author":"Li","year":"2018","journal-title":"Genome Biol"},{"issue":"9","key":"10.1016\/j.gendis.2023.03.017_bib59","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","article-title":"Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing","volume":"184","author":"Nu\u00f1ez","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib60","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2017.08.003","article-title":"In situ capture of chromatin interactions by biotinylated dCas9","volume":"170","author":"Liu","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib61","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/biom12050704","article-title":"CAPTURE of the human U2 snRNA genes expands the repertoire of associated factors","volume":"12","author":"Guiro","year":"2022","journal-title":"Biomolecules"},{"issue":"23","key":"10.1016\/j.gendis.2023.03.017_bib62","doi-asserted-by":"crossref","first-page":"15242","DOI":"10.3390\/ijms232315242","article-title":"Locus-specific isolation of the Nanog chromatin identifies regulators relevant to pluripotency of mouse embryonic stem cells and reprogramming of somatic cells","volume":"23","author":"Burramsetty","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41380-020-0721-9","article-title":"Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies","volume":"26","author":"Zetterberg","year":"2021","journal-title":"Mol Psychiatr"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","article-title":"Alzheimer's disease: abeta, tau and synaptic dysfunction","volume":"11","author":"LaFerla","year":"2005","journal-title":"Trends Mol Med"},{"issue":"5580","key":"10.1016\/j.gendis.2023.03.017_bib65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"7601","key":"10.1016\/j.gendis.2023.03.017_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib67","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1073\/pnas.1618657114","article-title":"Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase","volume":"114","author":"Sun","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib68","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.gendis.2023.03.017_bib69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","article-title":"CRISPR\/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer's disease","volume":"11","author":"Gy\u00f6rgy","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3A","key":"10.1016\/j.gendis.2023.03.017_bib70","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(97)00262-3","article-title":"Current concepts in the pathogenesis of Alzheimer's disease","volume":"103","author":"Carr","year":"1997","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.gendis.2023.03.017_bib71","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"issue":"5123","key":"10.1016\/j.gendis.2023.03.017_bib72","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.gendis.2023.03.017_bib73","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib74","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.25455","article-title":"Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in Alzheimer disease","volume":"85","author":"Wadhwani","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gendis.2023.03.017_bib75","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib76","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid \u03b2 oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","article-title":"Neuropathology and biochemistry of a\u03b2 and its aggregates in Alzheimer's disease","volume":"129","author":"Thal","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2020.11.002","article-title":"Transformative network modeling of multi-omics data reveals detailed circuits, key regulators, and potential therapeutics for Alzheimer's disease","volume":"109","author":"Wang","year":"2021","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.gendis.2023.03.017_bib80","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson's disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.gendis.2023.03.017_bib81","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and Parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib82","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s12035-017-0535-1","article-title":"A clinical and molecular genetic study of 50 families with autosomal recessive Parkinsonism revealed known and novel gene mutations","volume":"55","author":"Taghavi","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"7","key":"10.1016\/j.gendis.2023.03.017_bib83","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update","volume":"31","author":"Nuytemans","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gendis.2023.03.017_bib84","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2017.04.008","article-title":"Trumping neurodegeneration: targeting common pathways regulated by autosomal recessive Parkinson's disease genes","volume":"298","author":"Scott","year":"2017","journal-title":"Exp Neurol"},{"issue":"7","key":"10.1016\/j.gendis.2023.03.017_bib85","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1515\/revneuro-2018-0105","article-title":"Immune system and new avenues in Parkinson's disease research and treatment","volume":"30","author":"Nasrolahi","year":"2019","journal-title":"Rev Neurosci"},{"issue":"6","key":"10.1016\/j.gendis.2023.03.017_bib86","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"20","key":"10.1016\/j.gendis.2023.03.017_bib87","first-page":"4507","article-title":"Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice","volume":"25","author":"Ishizu","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gendis.2023.03.017_bib88","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1038\/s41598-018-30436-3","article-title":"CRISPR\/Cas9-mediated generation of Guangxi Bama minipigs harboring three mutations in \u03b1-synuclein causing Parkinson's disease","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.10106","article-title":"Localization of autosomal recessive early-onset Parkinsonism to chromosome 1p36 (PARK7) in an independent dataset","volume":"51","author":"Bonifati","year":"2002","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib90","doi-asserted-by":"crossref","first-page":"469","DOI":"10.24272\/j.issn.2095-8137.2021.023","article-title":"PINK1 gene mutation by pair truncated sgRNA\/Cas9-D10A in cynomolgus monkeys","volume":"42","author":"Chen","year":"2021","journal-title":"Zool Res"},{"issue":"8","key":"10.1016\/j.gendis.2023.03.017_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb1540","article-title":"Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson's disease-linked DNAJC6 mutations","volume":"7","author":"Wulansari","year":"2021","journal-title":"Sci Adv"},{"issue":"14","key":"10.1016\/j.gendis.2023.03.017_bib92","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1523\/JNEUROSCI.1508-21.2022","article-title":"S-nitrosylation of p62 inhibits autophagic flux to promote \u03b1-synuclein secretion and spread in Parkinson's disease and Lewy body dementia","volume":"42","author":"Oh","year":"2022","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.gendis.2023.03.017_bib93","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.26166","article-title":"Lewy body-like inclusions in human midbrain organoids carrying glucocerebrosidase and \u03b1-synuclein mutations","volume":"90","author":"Jo","year":"2021","journal-title":"Ann Neurol"},{"issue":"18","key":"10.1016\/j.gendis.2023.03.017_bib94","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib95","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012188","article-title":"Targeted attenuation of elevated histone marks at SNCA alleviates \u03b1-synuclein in Parkinson's disease","volume":"13","author":"Guhathakurta","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/crispr.2021.0025","article-title":"CRISPR-Cas9 gene editing protects from the A53T-SNCA overexpression-induced pathology of Parkinson's disease in vivo","volume":"5","author":"Yoon","year":"2022","journal-title":"CRISPR J"},{"issue":"6","key":"10.1016\/j.gendis.2023.03.017_bib97","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","article-title":"Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1\u03b1 transcription","volume":"155","author":"Ryan","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib98","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/cdd.2016.104","article-title":"Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation","volume":"24","author":"Delgado-Camprubi","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.gendis.2023.03.017_bib99","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-021-00243-4","article-title":"Parkinson's disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1\/Parkin-mediated mitophagy","volume":"10","author":"Ma","year":"2021","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.gendis.2023.03.017_bib100","doi-asserted-by":"crossref","first-page":"45883","DOI":"10.1038\/srep45883","article-title":"A novel tool for monitoring endogenous alpha-synuclein transcription by NanoLuciferase tag insertion at the 3'end using CRISPR-Cas9 genome editing technique","volume":"8","author":"Basu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2023.03.017_bib101","doi-asserted-by":"crossref","first-page":"101385","DOI":"10.1016\/j.arr.2021.101385","article-title":"Gene targeting techniques for Huntington's disease","volume":"70","author":"Fields","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib102","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington's disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.gendis.2023.03.017_bib104","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.gendis.2023.03.017_bib105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-7825-0_6","article-title":"Mouse models of Huntington's disease","volume":"1780","author":"Farshim","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib106","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib107","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","article-title":"A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington's disease","volume":"173","author":"Yan","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2023.03.017_bib108","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2018.00075","article-title":"Precise excision of the CAG tract from the huntingtin gene by Cas9 nickases","volume":"12","author":"Dabrowska","year":"2018","journal-title":"Front Neurosci"},{"issue":"7","key":"10.1016\/j.gendis.2023.03.017_bib109","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease","volume":"127","author":"Yang","year":"2017","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.gendis.2023.03.017_bib110","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1073\/pnas.1524575113","article-title":"Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib111","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.gendis.2023.03.017_bib112","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/brain\/awab190","article-title":"Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study","volume":"144","author":"Liu","year":"2021","journal-title":"Brain"},{"issue":"Suppl 2","key":"10.1016\/j.gendis.2023.03.017_bib113","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/neuonc\/not151","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.gendis.2023.03.017_bib114","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrclinonc.2016.36","article-title":"Driving CAR T-cells forward","volume":"13","author":"Jackson","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib116","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1158\/2159-8290.CD-20-1243","article-title":"CRISPR screening of CAR T cells and cancer stem cells reveals critical dependencies for cell-based therapies","volume":"11","author":"Wang","year":"2021","journal-title":"Cancer Discov"},{"issue":"7906","key":"10.1016\/j.gendis.2023.03.017_bib117","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","article-title":"CAR T cell killing requires the IFN\u03b3R pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature"},{"issue":"47","key":"10.1016\/j.gendis.2023.03.017_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.gendis.2023.03.017_bib119","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fneur.2017.00301","article-title":"Drug-resistant epilepsy: multiple hypotheses, few answers","volume":"8","author":"Tang","year":"2017","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.gendis.2023.03.017_bib120","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00415-017-8394-2","article-title":"Recent advances in epilepsy","volume":"264","author":"Manford","year":"2017","journal-title":"J Neurol"},{"issue":"7835","key":"10.1016\/j.gendis.2023.03.017_bib121","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2933-1","article-title":"Discoveries in structure and physiology of mechanically activated ion channels","volume":"587","author":"Kefauver","year":"2020","journal-title":"Nature"},{"issue":"10172","key":"10.1016\/j.gendis.2023.03.017_bib122","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"issue":"161","key":"10.1016\/j.gendis.2023.03.017_bib123","doi-asserted-by":"crossref","first-page":"161ra152","DOI":"10.1126\/scitranslmed.3004190","article-title":"Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy","volume":"4","author":"Wykes","year":"2012","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.gendis.2023.03.017_bib124","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awaa045","article-title":"In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy","volume":"143","author":"Colasante","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.gendis.2023.03.017_bib125","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1038\/srep06930","article-title":"Profiling status epilepticus-induced changes in hippocampal RNA expression using high-throughput RNA sequencing","volume":"4","author":"Hansen","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2023.03.017_bib126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.expneurol.2018.10.010","article-title":"Gene expression profiling in a mouse model of Dravet syndrome","volume":"311","author":"Hawkins","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1016\/j.gendis.2023.03.017_bib127","doi-asserted-by":"crossref","first-page":"105141","DOI":"10.1016\/j.nbd.2020.105141","article-title":"Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant","volume":"147","author":"Hawkins","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WCO.0000000000000902","article-title":"Dravet syndrome","volume":"34","author":"Lagae","year":"2020","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.gendis.2023.03.017_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-8749.2011.03964.x","article-title":"Dravet syndrome history","volume":"53","author":"Dravet","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib130","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/WNL.0000000000003716","article-title":"Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations","volume":"88","author":"Cetica","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib131","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymthe.2019.08.018","article-title":"dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice","volume":"28","author":"Colasante","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.gendis.2023.03.017_bib132","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s42003-021-02221-y","article-title":"Phenotypic analysis of catastrophic childhood epilepsy genes","volume":"4","author":"Griffin","year":"2021","journal-title":"Commun Biol"},{"issue":"11","key":"10.1016\/j.gendis.2023.03.017_bib133","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1093\/brain\/awz292","article-title":"Polygenic burden in focal and generalized epilepsies","volume":"142","author":"Leu","year":"2019","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.gendis.2023.03.017_bib134","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/WNL.0000000000004384","article-title":"Genetic epilepsy with febrile seizures plus: refining the spectrum","volume":"89","author":"Zhang","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.gendis.2023.03.017_bib135","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"6435","key":"10.1016\/j.gendis.2023.03.017_bib136","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/364362c0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"364","author":"Rosen","year":"1993","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib137","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"issue":"5870","key":"10.1016\/j.gendis.2023.03.017_bib138","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"issue":"5918","key":"10.1016\/j.gendis.2023.03.017_bib139","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.gendis.2023.03.017_bib140","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41593-020-0619-5","article-title":"Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72","volume":"23","author":"Zhu","year":"2020","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.gendis.2023.03.017_bib141","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-020-02154-6","article-title":"CRISPR deletion of the C9ORF72 promoter in ALS\/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration","volume":"140","author":"Krishnan","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.gendis.2023.03.017_bib142","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.molcel.2017.09.033","article-title":"Impeding transcription of expanded microsatellite repeats by deactivated Cas9","volume":"68","author":"Pinto","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.gendis.2023.03.017_bib143","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-021-00433-8","article-title":"Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction","volume":"16","author":"Perkins","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib144","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/17482968.2012.648645","article-title":"Misfolded SOD1 and ALS: zeroing in on mitochondria","volume":"13","author":"Pickles","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gendis.2023.03.017_bib146","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00401-005-1019-3","article-title":"Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models","volume":"110","author":"Kato","year":"2005","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.gendis.2023.03.017_bib147","doi-asserted-by":"crossref","first-page":"eaar3952","DOI":"10.1126\/sciadv.aar3952","article-title":"In vivo genome editing improves motor function and extends survival in a mouse model of ALS","volume":"3","author":"Gaj","year":"2017","journal-title":"Sci Adv"},{"issue":"3\u20134","key":"10.1016\/j.gendis.2023.03.017_bib148","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41434-019-0116-1","article-title":"The deletion of mutant SOD1 via CRISPR\/Cas9\/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"Duan","year":"2020","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.gendis.2023.03.017_bib149","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ymthe.2020.01.005","article-title":"Treatment of a mouse model of ALS by in vivo base editing","volume":"28","author":"Lim","year":"2020","journal-title":"Mol Ther"}],"updated-by":[{"DOI":"10.1016\/j.gendis.2024.101392","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000}}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304223001459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304223001459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:37:45Z","timestamp":1762450665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304223001459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2352304223001459"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2023.03.017","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR\/Cas9 system and its applications in nervous system diseases","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}